Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSaga Regulatory News (SAGA)

Share Price Information for Saga (SAGA)

Share Price is delayed by 15 minutes
Get Live Data
591.00    12.00 (2.07%)
Bid:
589.00
Ask:
590.00
Spread: 1.00 (0.17%)
Market Cap: £859.26m
SAGA Live PriceLast checked at - London Stock Exchange

Intraday Saga Share Chart

Acquisition

28 Jan 2015 07:00

RNS Number : 3151D
SAGA PLC
28 January 2015
Β 

Saga plc

Saga acquires iconic British motorbike insurance company Bennetts28 January 2015

Acquisition highlights

Β· Bennetts is the most customer-endorsed bike insurer in the market, with over 200,000 current customers. Saga provides insurance services for 20,000 customers with motorbikes.

Β· 43% of Bennetts customers are over 50 years of age, and 77% over 40 years of age. Access to Saga's database of 10.6m people will allow Bennetts to drive further growth.

Β· Saga will pay Β£26.26 million in cash for the entire share capital of Bennetts. The acquisition is in line with Saga's strategy to expand its insurance offering via broked services.

Saga plc ("Saga") today announces that it has agreed to acquire Bennetts, the UK's premier motorbike insurance specialist, as a further step in the implementation of Saga's strategy to enhance the range of insurance solutions it provides.

Bennetts, which Saga has agreed to acquire from BGL Group, provides insurance cover for more than 200,000 customers. 43% of its customers are over 50 years of age and 77% are over 40 years of age although Saga will continue to serve bikers of all ages under the highly-rated Bennetts brand, which is the most peer-recommended bike insurer in the market. It also hosts a successful online social network - 'bikesocial' - that sees over 180,000 visitors per month.

Bennetts will benefit from access to Saga's database of 10.6m people and from efficiencies gained by joining Saga's growing stable of insurance brands, which already includes Saga and Direct Choice.

Lance Batchelor, Group Chief Executive Officer, commented:

Β 

"We are delighted to add Bennetts to Saga's portfolio of highly-regarded brands. This fits with our strategic ambition to drive growth through our insurance broking operations. Bennetts sits perfectly within our business model: a capital light, cash generative business that will seamlessly integrate with our database to quickly deliver tangible returns.

"Our model works best where we can differentiate our service, leverage superior customer knowledge to tailor the best product for customers and create cross-selling opportunities. Bennetts will allow us to better meet the need for competitive bike insurance while also allowing us to increase our customer base."

Saga already provides insurance cover for around 20,000 motorbikes and together with Bennetts, Saga projects it will have a share of around 20% of the UK's motorbike insurance market.

Saga will pay Β£26.26 million in cash for the entire share capital of Bennetts, which reported revenue of Β£17 million and gross written premiums of Β£31 million in the year ended June 2014.

ENDS

Β 

For further information, please contact:

Β 

Saga plc

Tim McCall - Director of Corporate AffairsPaul Green

Director of Communications

Β 

Β 

Duncan Browne - Investor Relations Manager

+ 44 (0) 20 7654 2729 tim.mccall@saga.co.uk

+44(0)1303 776023

paul.green@saga.co.uk

Β 

+44 (0) 77 1044 0528duncan.browne@saga.co.uk

FTI Consulting

Paul Marriott / Lucinda Kemeny

+44 (0) 20 3727 1341 / 1580

paul.marriott@fticonsulting.comΒ 

lucinda.kemeny@fticonsulting.com

Β 

Β 

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
ACQEAAFXAELSEAF
Date   Source Headline
21st Sep 20171:39 pmRNSHolding(s) in Company
19th Sep 20172:34 pmRNSHolding(s) in Company
15th Sep 20172:06 pmRNSDirector/PDMR Shareholding
16th Aug 20173:13 pmRNSDirector/PDMR Shareholding
1st Aug 201711:31 amRNSTotal Voting Rights
18th Jul 20172:57 pmRNSDirector/PDMR Shareholding
14th Jul 20173:57 pmRNSDirector/PDMR Shareholding
5th Jul 201710:15 amRNSIssue of Equity
5th Jul 20179:00 amRNSDirector/PDMR Shareholding
5th Jul 20179:00 amRNSDirector/PDMR Shareholding
22nd Jun 20174:17 pmRNSResult of AGM
22nd Jun 20177:00 amRNSTrading Statement
21st Jun 20173:13 pmRNSDirector/PDMR Shareholding
19th Jun 20179:00 amRNSHolding(s) in Company
15th Jun 20173:50 pmRNSHolding(s) in Company
15th Jun 20173:40 pmRNSDirector/PDMR Shareholding
13th Jun 20173:44 pmRNSHolding(s) in Company
2nd Jun 20172:56 pmRNSHolding(s) in Company
30th May 20172:54 pmRNSDirector/PDMR Shareholding
26th May 20172:30 pmRNSHolding(s) in Company
17th May 20174:05 pmRNSDirector/PDMR Shareholding
16th May 20174:01 pmRNSHolding(s) in Company
15th May 20174:03 pmRNSHolding(s) in Company
15th May 20179:18 amRNSHolding(s) in Company
12th May 20171:40 pmRNSHolding(s) in Company
10th May 20177:00 amRNSRefinancing and launch of debut bond
8th May 20172:32 pmRNSDirector/PDMR Shareholding
8th May 20172:32 pmRNSDirector/PDMR Shareholding
28th Apr 201710:00 amRNSHolding(s) in Company
28th Apr 20179:00 amRNSNotice of AGM
20th Apr 20173:36 pmRNSDirector/PDMR Shareholding
20th Apr 20173:34 pmRNSDirector/PDMR Shareholding
13th Apr 201712:40 pmRNSHolding(s) in Company
29th Mar 20172:40 pmRNSDividend Declaration
29th Mar 20177:00 amRNSFinal Results
28th Mar 201711:17 amRNSNomination Committee Chairmanship changes
23rd Mar 20171:29 pmRNSHolding(s) in Company
23rd Mar 20171:26 pmRNSHolding(s) in Company
20th Mar 20173:14 pmRNSHolding(s) in Company
16th Mar 20173:25 pmRNSDirector/PDMR Shareholding
1st Mar 20173:21 pmRNSHolding(s) in Company
28th Feb 20177:00 amRNSStatement regarding Ogden Rate decision
16th Feb 20173:21 pmRNSDirector/PDMR Shareholding
16th Feb 20173:20 pmRNSHolding(s) in Company
20th Jan 20173:36 pmRNSHolding(s) in Company
18th Jan 20172:32 pmRNSHolding(s) in Company
18th Jan 20172:26 pmRNSDirector/PDMR Shareholding
17th Jan 20177:00 amRNSChange of Auditor
11th Jan 20177:00 amRNSTrading Update & Notice of Results
19th Dec 20167:00 amRNSBoard Changes

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.